Trump Says Tariffs Pushed Novartis to Expand Operations in US
President Donald Trump claimed that his tariffs were the reason for Novartis AG, a Swiss pharmaceutical company, to expand its manufacturing operations in the United States. This statement came after a meeting between Trump and Novartis CEO Vas Narasimhan at the White House on Wednesday. The article does not provide any additional details about the specific expansions or investments Novartis is making in the US. It also does not mention whether Novartis has confirmed Trump's assertion that the tariffs were the primary driver behind their decision to expand their US footprint. The article is brief and does not offer any further context or analysis regarding the potential impact of tariffs on the pharmaceutical industry or Novartis's business strategy. It simply reports on the claim made by President Trump during his meeting with the Novartis CEO.
Source: For the complete article, please visit the original source link below.
